posted on 2004-03-01, 00:00authored byGregory E Miller, Sheldon CohenSheldon Cohen, Sarah Pressman, Anita Barkin, Bruce S Rabin, John J Treanor
Objectives: This study attempted to determine whether stress of moderate intensity could modulate the antibody response to an
influenza vaccination in healthy young adults, identify critical periods during which stress could influence antibody response, and
delineate behavioral and biological pathways that might explain relations between stress and antibody. Methods: A cohort of 83
healthy young adults underwent 13 days of ambulatory monitoring before, during, and after vaccination. Four times daily, subjects
reported the extent to which they felt stressed and overwhelmed and collected a saliva sample that was later used to measure
cortisol. A battery of health practices (cigarette smoking, alcohol use, physical activity, sleep hygiene) was assessed daily. Antibody
titers to the vaccine components were measured at baseline and at 1-month and 4-month follow-up assessments. Results and
Conclusions: To the extent that they reported higher levels of stress across the monitoring period, subjects exhibited poorer
antibody responses to the New Caledonia strain of the vaccine. Stress ratings on the 2 days before the vaccine and the day it was
given were not associated with antibody response. However, the 10 days afterward appeared to be a window of opportunity during
which stress could shape the long-term antibody response to varying degrees. With respect to potential mediating pathways, little
evidence emerged in favor of cortisol secretion, alcohol consumption, physical activity, or cigarette smoking. However, analyses
were consistent with a pattern in which feelings of stress and loss of sleep become locked into a feed-forward circuit that ultimately
diminishes the humoral immune response. These findings may shed light on the mechanisms through which stress increase
vulnerability to infectious disease.